Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from NATCO Pharma Limited ( (IN:NATCOPHARM) ).
NATCO Pharma Limited has notified the stock exchanges that it has published a notice of postal ballot in the newspapers Financial Express and Nava Telangana on February 21, 2026, in line with Regulation 47 of SEBI’s Listing Obligations and Disclosure Requirements. The company stated that copies of these publications, relating to the shareholder postal ballot process, are available on its website, underscoring compliance with disclosure norms and transparent communication with investors.
The disclosure highlights NATCO Pharma’s adherence to regulatory requirements and formal communication channels with its shareholders through both print and digital platforms. By publicizing the postal ballot notice in leading newspapers and hosting the material online, the company reinforces governance standards and facilitates informed participation of investors in corporate decision-making.
More about NATCO Pharma Limited
NATCO Pharma Limited is an Indian pharmaceutical company engaged in the development, manufacture, and marketing of branded and generic formulations and active pharmaceutical ingredients. The company operates in the healthcare sector with a focus on domestic and international markets, and its shares are listed on BSE and the National Stock Exchange of India under the scrip code NATCOPHARM.
Average Trading Volume: 146,651
Technical Sentiment Signal: Buy
Current Market Cap: 159.5B INR
For a thorough assessment of NATCOPHARM stock, go to TipRanks’ Stock Analysis page.